Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Jul;77(1):7–10.

2-Mercaptoethanol and n-acetylcysteine enhance T cell colony formation in AIDS and ARC.

J Wu 1, E M Levy 1, P H Black 1
PMCID: PMC1541915  PMID: 2527652

Abstract

One contributing factor to the loss of T cells in AIDS may be the impaired ability of T cell precursors to expand, as reflected in a decreased ability of patient cells to form T cell colonies in agar. We and others have noted such a defect in people with AIDS and ARC, and have found that suppressor cells and suppressive plasma contribute to decreased T-CFC formation. We report here that the reducing agents 2-mercaptoethanol (2-ME) and n-acetyl cysteine (NAC) can enhance colony formation in vitro. In part, 2-ME can reverse the defect in T cell colony-forming cells (T-CFC) formation by overcoming the effect of suppressor cells. In a group of 46 AIDS patients, T-CFC formation was initially 42 +/- 8% (mean +/- s.e.) that of control levels. 2-ME caused an increase of 401 +/- 76% in T-CFC formation which was significantly greater than the increase in control T-CFC formation; it also significantly enhanced T-CFC formation by cells from ARC patients. Suppressor cell activity from ten AIDS patients decreased from 58 +/- 21% to 12 +/- 10% when 2-ME was added. Similar data were obtained from 14 ARC patients. NAC, a related antioxidant with low toxicity, also enhanced T-CFC in cells of AIDS and ARC patients. Vitamin C generally did not increase T-CFC formation. The data suggest that certain antioxidants such as 2-ME and NAC may be useful in treatment protocols to enhance T cell numbers in patients with AIDS or ARC.

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelsson J. A., Källén B., Nilsson O., Tropé C. Effect of 2-mercaptoethanol on the mixed leukocyte reaction in man. Probable effect on blastogenic factor stabilization. Acta Pathol Microbiol Scand C. 1976 Oct;84C(5):390–396. doi: 10.1111/j.1699-0463.1976.tb00046.x. [DOI] [PubMed] [Google Scholar]
  2. Chaplin D. D., Wedner J. H. Inhibition of lectin-induced lymphocyte activation by diamide and other sulfhydryl reagents. Cell Immunol. 1978 Mar 15;36(2):303–311. doi: 10.1016/0008-8749(78)90274-5. [DOI] [PubMed] [Google Scholar]
  3. Claësson M. H., Flad H. D., Opitz H. G. B and T lymphocyte colony formation in agar: 2-mercaptoethanol-activated albumin can substitute for 2-mercaptoethanol. Cell Immunol. 1979 Sep 1;46(2):398–404. doi: 10.1016/0008-8749(79)90426-x. [DOI] [PubMed] [Google Scholar]
  4. De Flora S., Rossi G. A., De Flora A. Metabolic, desmutagenic and anticarcinogenic effects of N-acetylcysteine. Respiration. 1986;50 (Suppl 1):43–49. doi: 10.1159/000195087. [DOI] [PubMed] [Google Scholar]
  5. Fanger M. W., Hart D. A., Wells J. V., Nisonoff A. Enhancement by reducing agents of the transformation of human and rabbit peripheral lymphocytes. J Immunol. 1970 Oct;105(4):1043–1045. [PubMed] [Google Scholar]
  6. Fauci A. S., Macher A. M., Longo D. L., Lane H. C., Rook A. H., Masur H., Gelmann E. P. NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med. 1984 Jan;100(1):92–106. doi: 10.7326/0003-4819-100-1-92. [DOI] [PubMed] [Google Scholar]
  7. Forsdyke D. R., David C. M. Comparison of enhancement by heated serum and 2-mercaptoethanol of lymphocyte transformation induced by high concentrations of concanavalin A. Cell Immunol. 1978 Mar 1;36(1):86–96. doi: 10.1016/0008-8749(78)90253-8. [DOI] [PubMed] [Google Scholar]
  8. Heber-Katz E., Click R. E. Immune responses in vitro. V. Role of mercaptoethanol in the mixed-leukocyte reaction. Cell Immunol. 1972 Nov;5(3):410–418. doi: 10.1016/0008-8749(72)90067-6. [DOI] [PubMed] [Google Scholar]
  9. Hoffeld J. T., Oppenheim J. J. Enhancement of the primary antibody response by 2-mercaptoethanol is mediated by its action on glutathione in the serum. Eur J Immunol. 1980 May;10(5):391–395. doi: 10.1002/eji.1830100514. [DOI] [PubMed] [Google Scholar]
  10. Laurence J., Gottlieb A. B., Kunkel H. G. Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions. J Clin Invest. 1983 Dec;72(6):2072–2081. doi: 10.1172/JCI111172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Laurence J., Mayer L. Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors. Science. 1984 Jul 6;225(4657):66–69. doi: 10.1126/science.6328662. [DOI] [PubMed] [Google Scholar]
  12. Levy E. M., Beldekas J. C., Mayer K. H., Black P. H. Defective T-cell differentiation in acquired immune deficiency syndrome (AIDS). J Clin Immunol. 1986 Mar;6(2):152–160. doi: 10.1007/BF00918748. [DOI] [PubMed] [Google Scholar]
  13. Metcalf D. Role of mercaptoethanol and endotoxin in stimulating B lymphocyte colony formation in vitro. J Immunol. 1976 Mar;116(3):635–638. [PubMed] [Google Scholar]
  14. Moldéus P., Cotgreave I. A., Berggren M. Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration. 1986;50 (Suppl 1):31–42. doi: 10.1159/000195086. [DOI] [PubMed] [Google Scholar]
  15. Winkelstein A., Kingsley L. A., Klein R. S., Lyter D. W., Evans T. L., Rinaldo C. R., Jr, Weaver L. D., Machen L. L., Schadle R. C. Defective T-cell colony formation and IL-2 receptor expression at all stages of HIV infection. Clin Exp Immunol. 1988 Mar;71(3):417–422. [PMC free article] [PubMed] [Google Scholar]
  16. Winkelstein A., Klein R. S., Evans T. L., Dixon B. W., Holder W. L., Weaver L. D. Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome. J Immunol. 1985 Jan;134(1):151–156. [PubMed] [Google Scholar]
  17. Ziment I. Acetylcysteine: a drug with an interesting past and a fascinating future. Respiration. 1986;50 (Suppl 1):26–30. doi: 10.1159/000195085. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES